Udaan’s pre-IPO top-up; Tata’s Assam chip hub test runHappy Monday! Udaan is in talks to raise fresh funds amid IPO talks. This and more in today's ETtech Morning Dispatch.
Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
Dr Reddy’s launches oral semaglutide in IndiaDr Reddys Laboratories has launched its oral semaglutide biosimilar for type 2 diabetes in India. The drug, Obeda, is available in three ta...
Dr Reddy's launches oral semaglutide biosimilar Obeda in IndiaDr. Reddy's Laboratories proudly presents Obeda, a groundbreaking oral semaglutide biosimilar for managing Type 2 diabetes in India. This i...
Dr Reddy’s Laboratories receives approval from Health Canada for its generic semaglutide injectionDr Reddy's Laboratories has achieved a significant milestone. Health Canada has approved its generic semaglutide injection. This makes Dr R...
PM to attend closing ceremony of Sikkim's 50 years of statehood celebrationsPrime Minister Narendra Modi will visit Sikkim from April 27 to attend the closing ceremony of its 50th statehood anniversary. He will inau...
Bengaluru property prices can rise by 20 to 40% in JP Nagar, Bannerghatta Road and these areas due to Yellow Line & Pink Line metro; reportBengaluru's real estate market is set for a significant boom. Property prices in key areas are projected to climb by up to 40% in the next ...
Jio preps May IPO; Wipro slips after resultsJio Platforms is edging towards a long-awaited IPO as markets wobble amid Iran tensions. This and more in today's ETtech Top 5.
Pharmacy startup Plazza in talks to raise $12-15 million from Accel, Nexus, ElevationPlazza, a quick medicine delivery startup, is in talks to secure $12-15 million in funding. This new capital will help Plazza expand its ph...
Air India, Tata Digital losses push Tata Sons’ new ventures towards Rs 29,000 crore hit: ReportTata Sons' new ventures face significant financial challenges. Projections indicate a combined loss of up to Rs 29,000 crore in FY26. Air I...
RCB vs CSK 2026 match tickets on sale: Check prices, how to buy, metro perks and entry rulesRCB vs CSK 2026 tickets: The highly anticipated RCB vs CSK 2026 match tickets, which went live on April 1, have officially sold out on the ...
Stocks in news: RIL, Adani Enterprises, Bajaj Housing, PB FintechIndian markets showed resilience, recovering some Budget-day losses. Several key companies are under the spotlight today. Bajaj Finance and...
MSN Labs ties up with Eli Lilly for baricitinib in IndiaAs part of the COVID treatment range, MSN has already launched Favilow (Favipiravir) in the strengths of 200mg, 400mg and 800mg and Oselow ...
MG Group plans to launch airport coach in January, eyes Rs 500 cr turnoverThe Columbus is also the country's first monocoque/ chassis-less coach bus and it is solely conceptualised, designed and manufactured by th...
Unichem Lab gets USFDA nod for schizophrenia tabletsUnichem Laboratories has received approval from the USFDA for its generic Quetiapine Fumarate tablets used for treatment of schizophrenia a...
MG Housing raises Rs 100 crore from Edelweiss, SMC Global for Dharuhera projectThe money raised will be used to complete construction, clear outstanding regulatory dues and some debt, and buy an additional 20 acres of ...
- Jubilant Life's four medicines get USFDA approval
Jubilant Life Sciences said it has received approvals from the US health regulator for 4 products that target CNS and CVS therapeutic areas.